Clinical Indications: 50 year old with a 3 year history of increasing LFT’s w/ family history of liver disease; patient has a history of liver damage and cirrhosis.
Dose: 5mCi Tc-99m-albumin colloid given i.v.
Results: normal liver/spleen scan; liver and spleen are within normal size limits; no evidence of hepatocellular dysfunction.
Clinical Indications: 48 year old male with end-stage renal disease due to polycystic kidney disease.
Dose: 5mCi Tc-99m-albumin colloid given i.v.
Results: normal liver/spleen scan with no hepatic or splenic cysts identified.
liver/spleen (normal #3) image#1 image #2
Clinical Indications: 26 year old patient w/ hepatitis C - test for liver function.
Dose: 5mCi Tc-99m-albumin colloid.
Results: normal liver/spleen scintigraphy.
Clinical Indications: 65 year old white male with an abnormal CT scan of liver, weight loss, abdominal pain and nausea.
Dose: 6mCi Tc-99m-albumin colloid given i.v.
Results: (1) normal sized liver (2) the multiple space-occupying defects and colloid distribution is consistent with metastatic disease to the liver; multicystic liver disease can have this appearance in the appropriate clinical setting.
Clinical Indications: 51 year old white female who has a polycystic kidney disease and chronic renal failure.
Dose: 5mCi Tc-99m-albumin colloid given i.v.
Results: multiple decreased uptake areas in the liver which could represent polycystic liver disease.
Clinical Indications: 62 year old female with history of hepatitis C, cirrhosis and thrombocytopenia which may be secondary to ITP.
Dose: 6mCi Tc-99m-albumin colloid given i.v.
Results: shrunken left hepatic lobe w/ heterogeneous distribution of activity; normal spleen.
Clinical Indications: 69 year-old white female w/ history of macrocytic anemia and thrombocytopenia - study done to evaluate spleen size.
Dose: 5 mCi Tc-99m-albumin colloid given i.v.
Results: colloid shift of radiopharmaceutical which is consistent with mild hepatocellular disease; normal spleen size without evidence of splenomegaly.
Clinical Indications: patient has a history of cirrhosis w/ elevated blood ammonia levels and pancytopenia.
Dose: 5 mCi Tc-99m-albumin colloid given i.v.
Results: findings are described above consistent w/ cirrhosis w/ splenomegaly; there are several photopenic foci, predominantly involving the liver dome; hepatocellular carcinoma or pseudo tumor cannot be excluded.
Clinical Indications: 71 year old white female history of alcohol abuse and positive antinuclear antibodies.
Dose: 10mCi Tc-99m-albumin colloid given i.v.
Results: patchy uptake of colloid in liver consistent with fatty infiltration or hepatitis; increased colloid activity in spleen relative to liver suggestive of shunting of portal flow to spleen; borderline hepatomegaly and splenomegaly; no discrete liver or splenic masses.
Clinical Indications: 50 year white female patient w/ SLE and APLS - study to rule out accessory spleen.
Dose: 8mCi Tc-99m-albumin colloid given i.v.
Results: normal homogeneous liver visualized; status/post splenectomy; no accessory of residual spleen visualized.